US Broker Ratings

iRadimed Corporation (IRMD) Stock Analysis: Exploring a 7.96% Potential Upside in the Medical Device Sector

iRadimed Corporation (NASDAQ: IRMD), a prominent player in the healthcare sector, specializes in creating innovative MRI-compatible medical devices. With a market capitalization of approximately $972 million,..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating Potential Upside in the Healthcare Sector

Phibro Animal Health Corporation (NASDAQ: PAHC) has emerged as a formidable player in the healthcare sector, particularly within the niche of drug manufacturing for specialty and..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Exploring a 109.62% Upside Potential

Nurix Therapeutics, Inc. (NRIX), a leading player in the biotechnology sector, is capturing attention with its remarkable potential for substantial growth. Based in San Francisco, the..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Exploring a Potential 190% Upside

Vir Biotechnology, Inc. (NASDAQ: VIR), a prominent player in the biotechnology sector, has carved out a niche in the healthcare landscape by focusing on the development..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: A Promising Biotech with 114% Potential Upside

ArriVent BioPharma, Inc. (NASDAQ: AVBP) stands out in the biotechnology industry, not only for its cutting-edge cancer therapies but also for its compelling investment potential. With..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: Exploring a Potential 223.81% Upside

For investors eyeing opportunities in the healthcare sector, Akebia Therapeutics, Inc. (NASDAQ: AKBA) presents a compelling case with its focus on innovative therapies for kidney diseases...

AMN Healthcare Services Inc (AMN): Investor Outlook Amidst Challenging Valuation and Growth Metrics

AMN Healthcare Services Inc (NYSE: AMN) navigates a complex landscape in the healthcare sector, offering a variety of technology-enabled workforce solutions and staffing services essential for..

GH Research PLC (GHRS) Investor Outlook: Biotech Stock Poised for 147.96% Upside Potential

GH Research PLC (NASDAQ: GHRS), a clinical-stage biopharmaceutical company based in Dublin, Ireland, is making waves in the biotechnology sector with its focus on innovative treatments..

Day One Biopharmaceuticals, Inc. (DAWN) Stock Analysis: Unraveling a Potential 234.60% Upside in the Biotech Arena

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) is capturing investor attention with a notable potential upside of 234.60%, as the company positions itself on the cutting edge..

Nuvation Bio Inc. (NUVB) Stock Analysis: Biotechnology Innovator with 58.58% Potential Upside

Nuvation Bio Inc. (NUVB), a clinical-stage biopharmaceutical company based in New York, is capturing investor attention with its promising oncology pipeline and significant potential upside. Trading..

uniQure N.V. (QURE) Stock Analysis: A Closer Look at Its 9.79% Potential Upside and Robust Pipeline

Investors eyeing the biotechnology sector may find uniQure N.V. (QURE), a leading player in the gene therapy space, an intriguing opportunity. With a market capitalization of..

STAAR Surgical Company (STAA) Stock Analysis: Navigating the Healthcare Sector with a 186.83 Forward P/E

STAAR Surgical Company (NASDAQ: STAA) stands as a noteworthy entity in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization..

Delcath Systems, Inc. (DCTH) Stock Analysis: Major Upside Potential with a 150% Target Price Surge

For investors keen on tapping into the healthcare sector, Delcath Systems, Inc. (NASDAQ: DCTH) presents an intriguing opportunity. With a focus on innovative treatments for liver..

Immunome, Inc. (IMNM) Stock Analysis: Unpacking a 50% Potential Upside in Biotech

Immunome, Inc. (NASDAQ: IMNM) is capturing the attention of investors in the healthcare sector with its promising biotech developments and the potential for significant stock appreciation...

CeriBell, Inc. (CBLL) Stock Analysis: A 151% Potential Upside in the Healthcare Sector

CeriBell, Inc. (CBLL), a promising player in the healthcare sector, is capturing investor attention with its innovative approach to neurological care. The company, headquartered in Sunnyvale,..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: A High-Stakes Biotech with 43% Upside Potential

Praxis Precision Medicines, Inc. (PRAX) is gaining attention in the biotechnology sector, particularly among investors with a keen interest in companies developing breakthrough therapies for central..

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: Navigating the Biotech Waters with a 48.8% Revenue Boost

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) has been making waves in the biotechnology industry with its innovative approach to addressing chronic endocrine and neurological diseases. Headquartered..

Cronos Group Inc. (CRON) Stock Analysis: Navigating a 20.5% Revenue Growth Amidst Market Challenges

Cronos Group Inc. (NASDAQ: CRON), a prominent player in the cannabinoid sector, is capturing investor attention with its noteworthy 20.5% revenue growth, despite facing a complex..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: A Potential 56.69% Upside in the Biotech Arena

Arcus Biosciences, Inc. (NASDAQ: RCUS) is making waves in the biotechnology sector with its promising portfolio of cancer therapies. As a clinical-stage biopharmaceutical company, Arcus is..

Syndax Pharmaceuticals, Inc. (SNDX) Investor Outlook: A Potential 186% Upside on Promising Cancer Therapies

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) stands out in the biotechnology sector with a compelling growth narrative, particularly for investors seeking exposure to innovative cancer treatments. With..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds